Posted on: Thursday, 3 February 2011, 00:00 CST

Lab findings show NutraSilver’s ability to thwart ravaging effects of illness.

Reno, Nevada (Vocus/PRWEB) February 03, 2011

NutraSilver®, a top quality advanced colloidal silver that has shown a natural ability to assist with such conditions as Morgellons, Lyme disease and more, has now demonstrated its ability to help those impacted by Methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant Staph infection that affects thousands of people each year. In testing completed by BioScience Laboratories, it was shown that just one drop of NutraSilver killed 1.33 billion cells of MRSA in 60 seconds. This report is a significant finding for the medical community that has labored to find a non-toxic product that is effective against an infection that can have deadly consequences, especially in those with compromised immunity.

The effectiveness of NutraSilver against MRSA comes as no surprise to those who have worked so hard to introduce its benefits to the medical community and the world at large. Made from a powerful organic combination of real silver and distilled clustered water, NutraSilver has been proven to eliminate many forms of bacteria and germs by simply blocking the ability for microorganisms to breathe. it is in this way, say those who manufacture NutraSilver, that this advanced colloidal silver works to literally “snuff” out MRSA virus.“The lab results speak for themselves,” says company president Russell Altman. “This represents a significant medical breakthrough; one that can change the face of healthcare going forward and one that represents a turning point in dealing with those diseases that have come to be considered untreatable.”

In fact, says Altman, with so many strains of illness becoming resistant to traditional forms of treatment, it will become increasingly important for all of us – as advocates for our own healthcare – to better understand natural treatments that not only speak to illness but also foster overall health for a lifetime.

“NutraSilver is not meant to just react to illness, but to offer a proactive form of healthcare so that we can maintain great health and natural vigor throughout our life,” says Altman. “NutraSilver has been shown to be effective in helping those who suffer from a host of illnesses – including, as we have seen from our lab results and patient testimonials, MRSA. but it can also be a cornerstone of health; used by those who value a strong immune system, renewed energy and great health.”

Manufactured in a federally-inspected manufacturing facility, NutraSilver is a scientifically engineered product that relies on pure silver and distilled clustered water to fight germs and bacteria. the end result is a formulation that promotes general well-being by making it very difficult for pathogens to survive. Users turn to NutraSilver to treat various symptoms and help prevent illness.

To learn more about NutraSilver® CLICK HERE

For the original version on PRWeb visit: prweb.com/releases/prweb2011/2/prweb8109173.htm

More News in this Category

Posted on: Tuesday, 14 December 2010, 00:01 CST

The Crohn’s & Colitis Foundation was proud to honor three leaders in the field of IBD research and treatment on Friday, December 10th at its 2010 Advances in Inflammatory Bowel Diseases Clinical & Research Conference (AdvancesInIBD.com) in Hollywood, Florida.

New York, NY (Vocus) December 13, 2010

the Crohn’s & Colitis Foundation was proud to honor three leaders in the field of IBD research and treatment on Friday, December 10th at its 2010 Advances in Inflammatory Bowel Diseases Clinical & Research Conference (AdvancesInIBD.com) in Hollywood, Florida.

The award recipients – Claudio Fiocchi, MD; William Sandborn, MD; and Lloyd Mayer, MD – were nominated by the CCFA’s National Scientific Advisory Committee (NSAC) for their dedication to improving the quality of life of the 1.4 million Americans suffering from Crohn’s disease and ulcerative colitis, chronic and often debilitating digestive diseases.

Dr. Fiocchi, Vice Chair for Research in the Department of Gastroenterology and Hepatology at the Cleveland Clinic has studied T cell function in the normal and IBD-involved intestinal mucosa for the past 30 years. For his unfaltering efforts, he was selected to receive the prestigious Henry D. Janowitz Lifetime Achievement Award in IBD. This award is presented annually to the research scientist who has demonstrated a career-long dedication toward the understanding of these devastating digestive diseases. during the last two decades Dr. Fiocchi has gone above and beyond expectations with his studies exploring the broad field of immune-non-immune cell interactions in IBD and fostering the study of pediatric IBD. Dr. Fiocchi has trained a large number of young investigators that are new leaders in IBD and has helped expand research in IBD worldwide.

Dr. Sandborn, the incoming Chief of the Division of Gastroenterology and Professor of Clinical Medicine at the University of California, San Diego, is no stranger to success. From 1993 until the present time he has been on the faculty of the Mayo Clinic and has published over 350 peer-reviewed articles for esteemed journals, such as the new England Journal of Medicine and the Annals of Internal Medicine. For his continued contribution toward advancing the field of IBD treatment, through clinical trials and clinical pharmacology, Dr. Sandborn was awarded with the 2010 CCFA Scientific Achievement Award in Clinical Research.

Dr. Mayer, Chair of the Immunology Institute and the Chief of the Division of Clinical Immunology at the Mount Sinai Medical Center and Professor of Immunology and the Dorothy and David Merksamer Professor of Medicine, currently holds five active grants from the National Institutes of Health on immunoregulatory mechanisms and responses in the intestine. he is also the principle investigator of the NIH immunobiology training grant. he is also the Chairman of the CCFA NSAC. he was the recipient of the 2000 CCFA Scientific Achievement Award and now, 10 years later, Dr. Mayer is being honored once again for his innovations in basic research in the field of IBD.

“The Crohn’s & Colitis Foundation couldn’t be more thrilled to honor these esteemed members of the scientific community,” says Richard J. Geswell, President of the Crohn’s & Colitis Foundation of America. “We look forward to the innovations their research will bring in the coming years.”

About Crohn’s Disease and Ulcerative ColitisCrohn’s disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn’s disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn’s disease or ulcerative colitis, with as many as 150,000 under the age of 18. most people develop the diseases between the ages of 15 and 35.

About the Crohn’s & Colitis Foundation of AmericaThe Crohn’s & Colitis Foundation of America’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. the Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends goes to mission-critical programs. the Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau’s Wise Giving Alliance and the American Institute of Philanthropy. For more information, contact the Foundation at 800-932-2423 or visit the CCFA web site at ccfa.org. Join CCFA on Facebook at apps.facebook.com/supportccfa/ and follow CCFA on Twitter at twitter.com/ccfa.

About Advances in IBD, Crohn’s & Colitis Foundation’s Clinical & Research ConferenceThe Advances in Inflammatory Bowel Disease, Crohn’s & Colitis Foundation’s Clinical & Research Conference has grown to become the foremost annual event for investigators and clinicians to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with inflammatory bowel diseases. Conference attendees gained insight from expert faculty on cutting-edge research breakthroughs and advancements in IBD patient care. more than 1,200 healthcare professionals attended the conference— the largest annual event in the United States dedicated to the state-of-the-art in basic and clinical research as well as clinical management of patients with IBD. Visit advancesinibd.com for more information. MEDIA CONTACT:

Ariella LevineCrohn’s & Colitis Foundation 646.943.7430alevine(at)ccfa(dot)org

For the original version on PRWeb visit: prweb.com/releases/prweb2010/12/prweb4880724.htm

More News in this Category

West Portsmouth, OH (Vocus) November 29, 2010

BioVeda Health and Wellness Centers, LLC is pleased to announce the introduction of a new smoking cessation program now available at BioVeda Health and Wellness Center of Portsmouth, OH. the center, headed by Dr. Richard Dustman, is successfully managing patient health through a holistic program which combines acupuncture, applied kinesiology and homeopathy to boost the immune system, promote natural detoxification and increase core level energy, often resulting in the alleviation of symptoms associated with such conditions as allergies, IBS, chronic fatigue, migraines, skin conditions, and general pain and inflammation.

This clinic utilizes meridian and energy stress assessment to measure the patient’s neurological reactions to specific environmental substances and to determine which substances are negatively impacting the patient. the substances that trigger a physiological stress spike, which is measured by the body’s impedance to each substance, are recorded and then presented back to the patient during low level light therapy. Light therapy conditions the autonomic nervous system to react normally to the otherwise harmless substances.

The system is designed to reduce physiological stress, not to be confused with anxiety, which not only weakens the immune system, but is also the trigger for food allergies, seasonal allergies, pet allergies, asthma, eczema, migraines, shingles, celiac and numerous other auto-immune related conditions. How these specific substances affect the stress levels placed on our immune system has a direct impact on the quality of our daily lives.

The smoking cessation program uses light therapy and homeopathic remedies to help a person quit, while reducing cravings, side effects, stress and irritability. It helps to remove harmful toxins known to build in the blood, tissue and cells through habitual use of tobacco products. It is faster than traditional methodologies, requiring 3 visits over a one week period, along with the use of a herbal remedy and homeopathic supplement.

“I’m very excited about the opportunity to introduce the health benefits of this therapy and to aid smokers in quitting this dangerous habit. using a combination of homeopathy, supplements, and neurological reduction stress therapy, patients are reporting relief from a wide variety of symptoms associated with conditions such as allergies and chronic fatigue. we look forward to seeing patients in our Portsmouth office to assess their candidacy for the smoking cessation program,” states Dr. Dustman. BioVeda Health and Wellness Centers are being established across the country through BioVeda Health and Wellness Centers, LLC., based in Boca Raton, FL. Each clinic is independently owned and operated by a licensed physician. BioVeda, which means “knowledge and wisdom of the body,” reflects the vision and commitment of the BioVeda Health and Wellness Center of Portsmouth to alternative health care methods that can help thousands of patients reduce their level of suffering from common and debilitating symptoms and increase their overall health and wellness. Patients receive a customized treatment plan which best fit their individual symptoms and conditions; however, many patients notice significant results after just a single therapeutic session. the cost for therapy is very affordable and results are long-lasting.

BioVeda Health and Wellness Center of Portsmouth is now open and located at 4342 Gallia Street, Suite B, new Boston, OH 45662 877-375-3208. biovedaofportsmouth.com

For more information, to make an appointment, or for the BioVeda Health and Wellness Center™ closest to you, call 1-877-647-7566 or visit biovedawellness.com.

BioVeda Health and Wellness Centers are committed to the advancement of therapies that are affordable and effective in the management of chronic conditions and common symptoms without the use of pharmaceutical agents.

Media Alert: please consider BioVeda Health and Wellness Centers for stories related to the technology and advancement of drug-free therapies. for more information or to set up an appointment, please contact Beth Bay, Director of Marketing, 917-734-1523.

Nationwide Medical/Surgical Announces Preservative Free Flu Vaccine Available

Los Angeles, CA (Vocus) March 11, 2009

Nationwide Medical/Surgical, a leading provider of the flu shot across the nation, has announced the availability of a preservative-free flu vaccine.

The influenza virus, more commonly known as the flu, is a virus that ranges in severity of symptoms from mild to fatal. It is transmitted very easily. the best defense from the flu virus is an influenza vaccination. the influenza vaccine is comprised of weakened or dead viruses that are introduced to the body to allow the body to build up a defense for the flu. when a person who has received the vaccine and has built up antibodies is introduced to the virus, the resulting symptoms from this exposure are typically nonexistent or very mild for the patient.

Flu vaccines come in several forms. there is a flu shot, which is injected to the person via syringe. there is also a flu mist vaccine that is inhaled nasally. most versions of the flu vaccine contain Thimerosal, preservative containing mercury, used to prevent contamination across multi-dose vials of the influenza vaccine. Multi-dose flu vaccine vials are vials that contain several doses of the flu shot. the vial is closed shut with a rubber stopper, in which a syringe is inserted to gather the vaccine for each dose. the introduction of each syringe brings with it the chance for contamination.

Many flu vaccine manufacturers are creating single dose vials that do not require Thimerosal to prevent contamination to fill the need for preservative free flu shots as there is no repeated drawing upon the vial. many people are opting for this version of the flu vaccine as there are fears that Thimerosal can cause autism.Currently, there is no conclusive proof that Thimerosal found within the flu vaccine causes any side effects other than a red sore spot at the injection site, however further studies are being done. As a result, many who are receiving the flu vaccine (especially young children and pregnant women) are interested in a preservative free flu vaccine version.

To find out more information about the preservative free flu vaccine or to view all of the influenza vaccine products that Nationwide Medical/Surgical has to offer, visit nationwidemedical.net

CONTACT:Dan Blatt, 14141 Covello Street, Suite 6C(800) 997-8846Van Nuys, CA 91405Website: nationwidemedical.net

©Copyright 1997-2010, Vocus PRW Holdings, LLC. Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

1. Gulf View Walk In Clinic gets H1N1 Swine Flu Intranasal Vaccine Supply
2. Surgical Molded Face Duramask 1890 – 50ct Box
3. Swine flu vaccine could have major medical side effects
4. Harvard Medical School Releases Special Health Report on Swine Flu
5. Flu Armour N95 Surgical Respirator for Swine Flu